• Home
  • Search Results
  • Brain activity associated with placebo suppression of the urge-to-cough in humans.

Brain activity associated with placebo suppression of the urge-to-cough in humans.

American journal of respiratory and critical care medicine (2013-10-08)
Jennifer Leech, Stuart B Mazzone, Michael J Farrell

Antitussive therapies are accompanied by a substantial placebo effect, indicating that inhibitory circuits in the brain have a significant capacity to regulate cough neural processing. However, essentially nothing is known about the identity of these inhibitory circuits or how they reduce coughing. Understanding these processes may help develop more effective antitussive therapies in the future. To identify regional changes in human brain activity related to the urge-to-cough after placebo antitussive administration. Seventeen healthy participants undertook functional magnetic resonance imaging while completing a series of inhalations of capsaicin to induce the urge-to-cough. The resultant brain responses associated with capsaicin inhalation without any treatment were compared with those induced by capsaicin after placebo antitussive administration. There was a significant decrease in participants' ratings of urge-to-cough after the placebo antitussive administration. Brain activity associated with capsaicin inhalation was less in the somatosensory, primary motor, insula, and cingulate cortices during placebo antitussive trials compared with no treatment control subjects. By contrast, placebo trials were associated with increased activation in the prefrontal and left parietal cortices. Placebo-related decreases in urge-to-cough are accompanied by commensurate decreases in several brain regions activated during capsaicin inhalation, suggesting that beliefs about treatment can modify the central processing of inputs arising from the airways. The prefrontal cortex and posterior parietal cortex are likely to play an active role in the modification of airway sensory processing after administration of a placebo.

Product Number
Product Description

Capsaicin, ≥95%, from Capsicum sp.
Capsaicin, natural
Capsaicin, from Capsicum sp., ≥50% (HPLC)
Capsaicin, analytical standard
Capsaicin, European Pharmacopoeia (EP) Reference Standard